Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of HealthEquity, Inc. (NASDAQ:HQY)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of HealthEquity, Inc. (NASDAQ:HQY). In a filing disclosed on September 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in HealthEquity stock on July 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Mesabi Trust (NYSE:MSB) on 7/31/2026.
• Purchased $1,001 – $15,000 in shares of Praxis Precision Medicines (NASDAQ:PRAX) on 7/30/2026.
• Purchased $15,001 – $50,000 in shares of Alkermes (NASDAQ:ALKS) on 7/30/2026.
• Sold $15,001 – $50,000 in shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 7/30/2026.
• Sold $100,001 – $250,000 in shares of Alibaba Group (NYSE:BABA) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Adobe (NASDAQ:ADBE) on 7/24/2026.
• Sold $1,001 – $15,000 in shares of Viavi Solutions (NASDAQ:VIAV) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of SailPoint (NASDAQ:SAIL) on 7/21/2026.
• Purchased $1,001 – $15,000 in shares of Glacier Bancorp (NYSE:GBCI) on 7/21/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 7/21/2026.

HealthEquity Stock Down 2.8%

Shares of NASDAQ:HQY traded down $2.71 during trading on Tuesday, reaching $93.36. 872,971 shares of the company traded hands, compared to its average volume of 958,866. The firm has a fifty day simple moving average of $99.53 and a 200 day simple moving average of $88.86. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $107.62. The firm has a market cap of $7.72 billion, a P/E ratio of 33.70, a price-to-earnings-growth ratio of 1.52 and a beta of 0.22.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The business had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. The firm’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Analysts anticipate that HealthEquity, Inc. will post 3.93 earnings per share for the current fiscal year.

Insider Activity

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director owned 62,395 shares in the company, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,470 shares of the business’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the transaction, the executive vice president owned 56,643 shares of the company’s stock, valued at $5,381,085. The trade was a 4.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,456 shares of company stock worth $1,256,664 in the last three months. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Fifth Third Wealth Advisors LLC boosted its position in shares of HealthEquity by 4.2% in the first quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after acquiring an additional 116 shares during the period. Truist Financial Corp boosted its stake in HealthEquity by 4.9% in the fourth quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after purchasing an additional 119 shares in the last quarter. Fiduciary Trust Co lifted its holdings in HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock worth $348,000 after buying an additional 120 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of HealthEquity by 24.4% in the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares during the last quarter. Finally, Merit Financial Group LLC grew its position in shares of HealthEquity by 8.9% during the 3rd quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after buying an additional 172 shares during the period. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HQY. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, September 2nd. Royal Bank Of Canada raised their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research report on Wednesday, June 3rd. Telsey Advisory Group set a $111.00 target price on shares of HealthEquity in a research note on Friday, August 28th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. Finally, Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a research note on Thursday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and an average price target of $111.87.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.